Proton Therapy For
We know that perhaps the most difficult cancer is one suffered by a child. Parents do not want to watch their child suffer, and pediatric cancers can create acute pain and discomfort. The small bodies and organs of infants and children can be especially sensitive to rigorous cancer treatments and invasive surgical procedures, despite the best efforts of caring physicians and nurses. That is why we are encouraged by the success of Proton Therapy in reducing pain and suffering while increasing healing and positive results for the littlest patients. We believe that Proton Therapy is a breakthrough in the search for gentler cancer treatments for infants and children.
How Proton Therapy Improves Pediatric Cancer Treatment
Proton Therapy is highly targeted and zeroes in on the tumor and cancerous tissue, without harming the young, healthy tissues nearby. This is especially important when treating cancers in tiny, developing bodies. Proton Therapy aggressively treats the cancer while substantially reducing side effects that could impact your child’s quality of life. This advanced cancer therapy has been proven to protect vital organs, important tissues, nerves, and glands during treatment, while also decreasing the estimated risk of secondary malignancies. Proton Therapy holds the promise of more aggressively fighting pediatric cancers while keeping infants and children feeling better during treatment.
Pediatric Cancers Treated with Proton Therapy include:
- Astrocytoma and other Gliomas
- Atypical Teratoid/Rhabdoid Tumors
- Intracranial Germ Cell Tumors (Germinoma)
- Nasopharyngeal Carcinoma
- Juvenile Angiofibromas
- Ewing’s sarcoma/Primitive neuro-ectodermal tumor (PNET)
- Desmoid tumor
- Histiocytosis X
Proton therapy is becoming a mainstay for treating pediatric tumors. By sparing still-growing tissue in children, proton therapy can reduce growth defects and secondary tumors caused by traditional radiation.Dr A. Thornton
In the U.S., the number of pediatric cases treated with proton therapy increased by 62% between 2012 and 2016, according to the survey, with recognition that proton therapy offers lower radiation doses to children’s developing bodies and brains. Studies have demonstrated that cancer survivors can have up to 25 percent increased risk of developing secondary, radiation-induced tumors when treated with conventional radiotherapy.The National Association for Proton Therapy